Ferrovial's consortium, Top End Mobility Group, won the $8.9 billion contract to design, build, and operate Phase 1 of the I-285 East Express Lanes in Greater Atlanta. This project will add about 21 miles of express lanes connecting key highways to improve travel reliability and regional connectivity. The full project aims to create 37.5 miles of lanes, enhancing mobility across Fulton and DeKalb counties. Ferrovial brings experience from similar U.S. projects, supporting economic growth in the area.
Ferrovial's contract for the I-285 East Express Lanes project provides context for the Industrials sector on Pluang. As of Oct 16, 2026 01:01 WIB, 84 of 136 Industrials stocks rose while 51 fell. Notable movers include Rocket Lab USA Inc (RKLB) at USD 53.34 with a 1-day change of -9.91%, Byrna Technologies Inc (BYRN) at USD 4.96 with +6.67%, and Vertiv Holdings Co (VRT) at USD 209.26 with -6.09%.
Citigroup increased its price target for Krystal Biotech to $416 from $386, citing strong Q2 revenue of $119.2 million from its approved product Vyjuvek and encouraging early clinical data for KB113, a treatment for basal cell carcinomas in Gorlin sy...
Bank7 Corp. reported Q3 2026 earnings of $1.06 per share, slightly beating analyst estimates, while revenue of $23.37 million fell short and declined year-over-year. Despite lower revenue and earnings compared to last year, the bank continues to grow...
Scotiabank increased its price target for Targa Resources to $319 from $314, indicating a potential 12.7% upside from the current share price of around $283. Targa Resources, a key player in the midstream energy sector, is recognized as a top momentu...
Ericsson reported better-than-expected Q3 earnings with EPS of $0.18 and revenue of $5.91 billion, driven by strong demand in its mobile network segment. The Networks division showed 9% organic growth and a gross margin above guidance, but overall op...
The obesity treatment landscape is rapidly evolving with over 200 companies developing more than 200 pipeline drugs, including late-stage and early-stage clinical trials. Major pharmaceutical firms like Novo Nordisk and Eli Lilly are leading with inn...
